Harbeson S L, Abelleira S M, Akiyama A, Barrett R, Carroll R M, Straub J A, Tkacz J N, Wu C, Musso G F
Alkermes, Inc., Cambridge, Massachusetts 02139-4136.
J Med Chem. 1994 Sep 2;37(18):2918-29. doi: 10.1021/jm00044a013.
Peptidyl alpha-keto amides have been synthesized and tested as inhibitors of the cysteine protease calpain. A stereospecific synthesis was devised in which Cbz-dipeptidyl-alpha-hydroxy amides were oxidized with TEMPO/hypochlorite to the corresponding alpha-keto amides. This oxidation was accomplished in good yields and without epimerization of the chiral center adjacent to the ketone. The potent inhibition of porcine calpain I by the L,L diastereomers, combined with the poor inhibition by the L,D diastereomers, established the requirement for the all-L stereochemistry of the active inhibitor. The early lead inhibitors were very hydrophobic and, therefore, poorly soluble in aqueous solutions. Using the stereospecific route, new compounds were prepared with polar groups at the C- and N-termini. These modifications resulted in more soluble inhibitors that were still potent inhibitors of calpain. Studies of the stability of these alpha-keto amides showed that absolute stereochemistry can be maintained in acidic and unbuffered environments but general base-catalyzed epimerization of the chiral center adjacent to the ketone occurred rapidly. The alpha-hydroxy precursors were inactive as inhibitors of calpain, which supports the hypothesis that the alpha-keto compounds reversibly form an enzyme-bound tetrahedral species that results from the nucleophilic addition of the catalytic thiol of calpain to the electrophilic ketone of the inhibitor.
肽基α-酮酰胺已被合成并作为半胱氨酸蛋白酶钙蛋白酶的抑制剂进行了测试。设计了一种立体定向合成方法,其中用四甲基哌啶氧化物/次氯酸盐将苄氧羰基二肽基-α-羟基酰胺氧化为相应的α-酮酰胺。这种氧化反应产率良好,且与酮相邻的手性中心没有差向异构化。L,L非对映异构体对猪钙蛋白酶I有强效抑制作用,而L,D非对映异构体的抑制作用较弱,这表明活性抑制剂需要全L立体化学结构。早期的先导抑制剂疏水性很强,因此在水溶液中的溶解度很差。采用立体定向路线,在C端和N端制备了带有极性基团的新化合物。这些修饰产生了更易溶解的抑制剂,它们仍然是钙蛋白酶的强效抑制剂。对这些α-酮酰胺稳定性的研究表明,在酸性和无缓冲环境中可以保持绝对立体化学结构,但与酮相邻的手性中心会迅速发生一般碱催化的差向异构化。α-羟基前体作为钙蛋白酶抑制剂没有活性,这支持了以下假设:α-酮化合物可逆地形成一种酶结合的四面体物种,该物种是由钙蛋白酶的催化硫醇对抑制剂的亲电酮进行亲核加成产生的。